West Pharmaceutical Servs (NYSE:WST) reported quarterly earnings of $2.13 per share which beat the analyst consensus estimate of $1.68 by 26.79 percent. This is a 46.9 percent increase over earnings of $1.45 per share from the same period last year. The company reported quarterly sales of $844.900 million which beat the analyst consensus estimate of $779.974 million by 8.32 percent. This is a 21.05 percent increase over sales of $698.000 million the same period last year.